GW-H1

General Information


DRACP ID  DRACP01213

Peptide Name   GW-H1

Sequence  GYNYAKKLANLAKKFANALW

Sequence Length  20

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Induce apoptosis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
J5 [Human hepatocellular carcinoma] Hepatocellular carcinoma Carcinoma IC50=20.3 μM MTT assay 24 h Patent
AGS Gastric adenocarcinoma Carcinoma IC50=17 µM MTT assay 24 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  NIH 3T3: IC50=243 μM

Target  Not available

Affinity  Not available

Mechanism  GW-H1 treatment induced both apoptosis and autophagy of AGS cell line in the early stage, while caspase-dependent apoptosis was further enhanced by inhibition of autophagy at the final stage.

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01213

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C109H166N28O26

Absent amino acids  CDEHIMPQRSTV

Common amino acids  A

Mass  262379

Pl  10.58

Basic residues  4

Acidic residues  0

Hydrophobic residues  10

Net charge  4

Boman Index  -1234

Hydrophobicity  -34

Aliphatic Index  83.5

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  8480

Absorbance 280nm  446.32

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25380626

Title  Antimicrobial peptide GW-H1-induced apoptosis of human gastric cancer AGS cell line is enhanced by suppression of autophagy

Doi 10.1007/s11010-014-2264-3

Year  2015

Patent

Patent ID TWI448297B

Patent Title  A method of using novel synthetic peptides for the preparation of drugs with anti-liver cancer activity

Other Iinformation  Granted Patent; Family: 2s / 2ex; Family Jurisdictions: TW; Legal Status: Active; Application No: 99121957; Filed: Jul 5, 2010; Published: Aug 11, 2014; Earliest Priority: Jul 5, 2010; Granted: Aug 11, 2014

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.